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A good example!
International Journal of Infectious Diseases (2009) 13, 535—536
http://intl.elsevierhealth.com/journals/ijidIn this issue, Jun Yuan and colleagues report their investiga-
tion of an outbreak of Mycobacterium abscessus.1 As they
describe, they searched for all cases, determined the various
procedures received by cases and non-cases, and interviewed
and observed healthcare staff. Their investigation identified
lapses in infection control that were likely responsible for the
outbreak, and guided specific changes in procedures to pre-
vent future similar cases from the responsible clinic.
In a nosocomial outbreak, patients incur costs in the form
of ill health. With a successful investigation, these costs are
not wasted, but instead contribute to benefits for others in
the form of avoided future infections. This journal’s publica-
tion of Jun Yuan and colleagues’ report extends these ben-
efits far beyond one Chinese village, guiding healthcare
workers throughout the world to avoid similar events.
Their report touches on several key issues related to the
conduct of outbreak investigations, and also stimulates
thoughts about investigations not done.
Who decides to investigate?
Jun Yuan and colleagues report ‘‘a request to investigate’’,
but they do not describe the process that led to the request.
As in most other investigations, I suspect that a government
health officer decided to investigate based on information
about adverse events assembled and assessed by government
health staff.
But the trail from realization of adverse events to an
investigation does not — and should not — always stay within
the government’s health services. The World Alliance for
Patient Safety (WAPS), an arm of the World Health Organiza-
tion, notes that ‘‘Many health-care organizations are actively
encouraging patient engagement to reduce errors and help
understand the causes of harm’’, and recommends that
healthcare workers ‘‘embrace the concept of patient
engagement’’.2 In recent years, most states in the USA have
adopted laws and/or regulations requiring hospitals to report
hospital-acquired infections, andmost states make this infor-
mation available to the public.3DOI of original article: 10.1016/j.ijid.2008.11.024.
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Jun Yuan and colleagues ‘‘trained and required staff to follow
correct injection techniques’’. Notably, they do not report
negative outcomes for those who made errors, or compensa-
tion for injured patients. The focus of their intervention was
forward-looking, to prevent future infections.
In any nosocomial outbreak, the first people to realize
their infections may favor a backward-looking process to
generate compensation for themselves by identifying and
penalizing the perpetrators. Victims’ efforts to collect com-
pensation may motivate healthcare workers to obstruct a
search for more victims and a thorough elucidation of infec-
tion control lapses.
While victims pursuing their self-interest may under-
mine efforts to learn from adverse events, an informed
public acting in its self-interest — for safer healthcare —
will press for investigations that prioritize identifying and
correcting mistakes. Such investigations include a search
for all cases. The more cases found, the more certain it is
that an investigation will identify and remedy contributing
errors.
Similarly, health officials committed to safe care share the
public’s interest in forward-looking and thorough investiga-
tions. However, this shared interest can be undermined by
fear and ignorance. Health officials may fear that investiga-
tions will lead to public criticism. The public may not hear of
adverse events, or may not be aware that a few such events
signal a threat to their health.
Investigations not done
In general, I suspect estimates of disability-adjusted life years
saved due to outbreak investigations would show there are too
few investigations. Lack of investigations is particularly trou-
bling in sub-SaharanAfrica,where high prevalence of hepatitis
B, hepatitis C, and HIV infection coincides with frequent
unsafe injections4 and with unreliable sterilization of medical
instruments.5—8 Throughout sub-Saharan Africa, I have found
only one outbreak investigation for hepatitis B (in South Africa
during the early 1990s9) and none for hepatitis C or HIV
(although unexplained HIV infections are ubiquitous10,11).Published by Elsevier Ltd. All rights reserved.
536 EditorialYear-by-year, clusters of unexplained HIV infections come
to light in Africa. Some of these clusters are reported among
participants in foreign-funded research, so that not only host
governments but also foreign institutions (who bear some
responsibility to protect research participants) should con-
sider whether to investigate. For example, a randomized
controlled trial of male circumcision for HIV prevention in
Kisumu, Kenya, in 2002—06 reported four men with incident
HIV infection within 1 month after circumcision (three
reported no sexual contacts during the month).12 Similarly,
a case—control study of HIV incidence among women in
Malawi in 2003—05, found that 23 of 27 cases had received
recent hormone injections for birth control, and the adjusted
odds ratio for HIV incidence associated with such injections
was 10.4.13 It is not too late to investigate unexplained
infections in these two studies. Money is available; US law
lists outbreak investigations among the activities eligible for
US foreign aid authorized for HIV prevention in 2009—13.14
How to promote investigations?
What could be done to promote more forward-looking inves-
tigations? One option might be for governments to legislate
guidelines for investigations that protect cooperating health-
care workers. Another might be for concerned citizens to
bring public interest lawsuits, requesting courts to order
investigations of suspected nosocomial infections. A success-
ful public interest lawsuit in India — which led the Supreme
Court to order the Government to improve testing of blood
before transfusion — provides an inexact precedent.15
Public awareness of risks in air travel — from reports of
plane crashes — ensures that governments and airline com-
panies prioritize safety. More outbreak investigations could
do the same for healthcare. The report by Jun Yuan and
colleagues points the way, and that is the real strength of
their study.
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